MedTrace Logo

clOpidogrel "resIstaNce" in a Selected Population of Patients at a Tertiary Cardiovascular Center in Trinidad

NCT03667066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-09-27

No results posted yet for this study

Summary

The aim of this study was to determine the prevalence of clopidogrel resistance among a selected group of patients undergoing elective percutaneous coronary intervention and to observe whether there was any south-Asian (Indo-Trinidadian) predilection for HPR considering the well-established epidemiologic trends for accelerated CAD within this subgroup.

Conditions

  • Platelet Dysfunction

Interventions

DRUG

Clopidogrel

Patients who were on long-term (more than 3 months) of clopidogrel or received a loading dose more than 4 hours prior to elective percutaneous coronary intervention.

Sponsors & Collaborators

  • The University of The West Indies

    lead OTHER

Principal Investigators

  • Naveen A Seecheran, MBBS MSc · The University of The West Indies

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-01-01
Completion
2018-06-01
FDA Drug
Yes

Countries

  • Trinidad and Tobago

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667066 on ClinicalTrials.gov